Madhu P. Menon, MD, PhD, FCAP

Associate Professor, University of Utah School of Medicine

Specialties

• Hematopathology and hematology (benign and malignant)
• Molecular hematopathology
• Lymphomas (Hodgkin and non-Hodgkin)
• Leukemias

Education

• Medical Degree—Baroda Medical College, Maharaja Sayajirao University
• Doctorate Degree—Molecular Medicine, Huck Institute of Life Sciences, Pennsylvania State University
• Residency—Anatomic and Clinical Pathology, University of Massachusetts Medical School
• Fellowship—Hematopathology, National Institutes of Health/National Cancer Institute
• Fellowship—Hematopathology, Johns Hopkins University Hospital
• Fellowship—Hematopathology, George Washington University Hospital
• Fellowship—Postdoctoral Fellow, Maine Medical Center Research Institute

Certification/Affiliations

• American Board of Pathology, Hematopathology
• American Board of Pathology, Anatomic Pathology
• American Board of Pathology, Clinical Pathology
• LEAN Silver Certification, LEAN Training for Healthcare Leaders

Research Interests

• Diagnostic and prognostic markers in lymphomas
• Molecular characterization of lymphomas
• Biomarkers for early detection of progression and transformation of low-grade lymphomas

Awards

• 2018–2019 Teacher of the Year, Henry Ford Pathology Residency Program
• 2015–2016 Teacher of the Year, Henry Ford Pathology Residency Program
• 2014 Fellow, American Society for Clinical Pathology (FASCP)
• Dec 2011 Fellow, College of American Pathologists (FCAP)
• 2010 Stowell–Orbison Award Nominee, United States and Canadian Academy of Pathology (USCAP)
• 2010 Association of Indian Pathologists in North America (AIPNA) USCAP Poster Award
• 2009–2010 College of American Pathologists (CAP) Advanced Hematopathology Training Award
• Aug 2001–Aug 2003 J. Huck Institute of Life Sciences Predoctoral Fellowship Award in Molecular Medicine: Integrative Biosciences Program, Pennsylvania State University

Recent Publications

• Anderson J, et al. Discovery of G6PD deficiency in a patient with DUSP22-rearranged ALK-negative anaplastic large cell lymphoma in leukemic phase. Int J Lab Hematol, 2021. (Online ahead of print)
• Friedman B, et al. An elderly male with a chronic rash of the right foot. Ind Jour of Derm. 2020;65(3):222–24.
• Van Slambrouck C, et al. Diagnostic utility of STAT6(YE361) expression in classical Hodgkin lymphoma and related entities. Mod Pathol. 2020;33(5):834–45.
• Vaddepally RK, eta l. A rare case of follicular lymphoma transformed to a high-grade B-cell lymphoma in orbit. Clin Case Rep. 2019;7(5):1053–56.
• Karner KH, et al. Post-transplant CD4+ non-cytotoxic gamma delta T cell lymphoma with lymph node involvement. J Hematopathol. 2018;11:107.
• Kezlarian B, et al. GATA3 immunohistochemical staining in Hodgkin lymphoma: diagnostic utility in differentiating classic Hodgkin lymphoma from nodular lymphocyte predominant Hodgkin lymphoma and other mimicking entities. Appl Immunohistochem Mol Morphol. 2019 Mar;27(3):180–84.
• Datta L, et al. Plasmacytoid lymphocytes: a clue to dengue diagnosis. Blood. 2017;129(15):2202.
• Alikhan M, et al. Peripheral T-cell lymphomas of follicular helper T-cell type frequently display an aberrant CD3-/dimCD4+ population by flow cytometry: an important clue to the diagnosis of a Hodgkin lymphoma mimic. Mod Pathol. 2016;(10):1173–82.